Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Effectiveness of Delamanid-containing Regimen for Treatment of Patients With Multidrug-resistant Tuberculosis in China

NCT04421495 is registered in ClinicalTrials.gov with Beijing Chest Hospital as lead sponsor.

NCT NCT04421495
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04421495 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Effectiveness of Delamanid-containing Regimen for Treatment of Patients With Multidrug-resistant Tuberculosis in China
Lead sponsor
Beijing Chest Hospital
Phase
Phase 4
Overall status
Unknown status
Start date
July 16, 2020
Completion date
July 16, 2024
Enrollment
608 (actual)
Sites
25

Conditions

As the registry lists them; a condition with its own page is linked.

multidrug resistant tuberculosis